Early research (Phase 1)Study completedNCT00739453What this trial is testingDose-escalation Study of OSI-906 and Erlotinib (Tarceva®)Who this might be right forAdvanced Solid Tumors Astellas Pharma Inc 95
Early research (Phase 1)Study completedNCT02897375What this trial is testingPalbociclib With Cisplatin or Carboplatin in Advanced Solid TumorsWho this might be right forSolid NeoplasmStage III Pancreatic CancerStage IIIA Breast Cancer+14 more Emory University 71
Not applicableLooking for participantsNCT06101277What this trial is testingLocally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)Who this might be right forEsophageal CancerSmall Bowel CancerGastroesophageal-junction Cancer+8 more University of California, Davis 300
Large-scale testing (Phase 3)Study completedNCT00005590What this trial is testingLevofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or LymphomaWho this might be right forBrain and Central Nervous System TumorsBreast CancerExtragonadal Germ Cell Tumor+7 more Cancer Research Campaign Clinical Trials Centre
Early research (Phase 1)Study completedNCT00006340What this trial is testingGanciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr VirusWho this might be right forLeukemiaLymphomaPrecancerous Condition+1 more Boston Medical Center
Testing effectiveness (Phase 2)Study completedNCT00101348What this trial is testingErlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung CancerWho this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more National Cancer Institute (NCI) 66
Early research (Phase 1)UnknownNCT00562068What this trial is testingAlemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell LymphomaWho this might be right forLymphomaSmall Intestine Cancer Cancer Research UK 30
Not applicableStudy completedNCT04476082What this trial is testingNutrition in Gastrointestinal TumorsWho this might be right forPancreatic CancerOesophageal CancerColon Cancer+7 more University Medicine Greifswald 66
Early research (Phase 1)Study completedNCT03811652What this trial is testingA Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid TumorsWho this might be right forNon Small Cell Lung Cancer Squamous (NSCLC-Sq)Head and Neck Squamous Cell Carcinoma (HNSCC)Small Cell Lung Cancer (SCLC)+3 more MedImmune LLC 8
Early research (Phase 1)Looking for participantsNCT06307925What this trial is testingA Phase I Study to Evaluate the Safety, Pharmacokinetics and Antitumor Activity of HC010 in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor HC Biopharma Inc. 122
Not applicableLooking for participantsNCT06715839What this trial is testingTarget-specific immunoPET Imaging of Digestive System CarcinomaWho this might be right forMalignancyDigestive CancerDigestive System Neoplasm+12 more RenJi Hospital 400
Testing effectiveness (Phase 2)Active Not RecruitingNCT04083599What this trial is testingGEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid TumorsWho this might be right forMalignant Solid TumorNon-Small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)+3 more Genmab 350
Early research (Phase 1)Study completedNCT00003993What this trial is testingBryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or LymphomaWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific National Institute on Aging (NIA) 24
Early research (Phase 1)Study completedNCT00514306What this trial is testingStudy of Intermittent OSI-906 DosingWho this might be right forAdvanced Solid Tumors Astellas Pharma Inc 79
Early research (Phase 1)Study completedNCT02457793What this trial is testingThe Safety, Tolerability, and Effects of Cobimetinib and GDC-0994 in Patients With Locally Advanced or Metastatic Solid TumorsWho this might be right forNon-Small Cell Lung Cancer, Metastatic Colorectal Cancer, Metastatic Non Small Cell Lung Cancer, Metastatic Cancers, Melanoma Genentech, Inc. 24
Testing effectiveness (Phase 2)Ended earlyNCT05551117What this trial is testingVobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid TumorsWho this might be right forCastration-Resistant Prostatic CancerAndrogen-Independent Prostatic CancerAndrogen-Insensitive Prostatic Cancer+14 more MacroGenics 192
Early research (Phase 1)Active Not RecruitingNCT02817633What this trial is testingTSR-022 in Participants With Advanced Solid Tumors (AMBER)Who this might be right forNeoplasms Tesaro, Inc. 463
Testing effectiveness (Phase 2)UnknownNCT01142713What this trial is testingThe Impact of Patient Positioning and Use of Belly Board on Small Bowel and Urinary Bladder Volume Irradiated in Patients Receiving Radiotherapy for Rectal Cancer: A Prospective Phase II StudyWho this might be right forRectal Cancer Tel-Aviv Sourasky Medical Center 30
Not applicableStudy completedNCT00002520What this trial is testingPhysician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage CancerWho this might be right forBladder CancerBreast CancerColorectal Cancer+7 more Eastern Cooperative Oncology Group 434
Early research (Phase 1)Active Not RecruitingNCT05492682What this trial is testingSTART: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of CancerWho this might be right forMelanoma (Skin)Triple-Negative Breast CancerNon-Small Cell Lung Cancer+5 more Valo Therapeutics Oy 15